COc1ccc(OC)c(-c2csc(N(CC3CCCO3)C(=O)Cc3ccccc3)n2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?